Found's semaglutide page is the clearest supply-chain disclosure in this category attached to the least clear price.
The advertised figure is $149 for the first month, reflecting a $100 discount applied to today's checkout on plans including compounded semaglutide, valid once per account. What the plan costs from month two is not stated on the page.
For context, Found's compounded tirzepatide is published at $289 standard with a twelve-month rate of $179. Compounded semaglutide almost always prices below compounded tirzepatide across this market, so the standard rate is likely lower — but likely is not a number you should budget against.
What is disclosed is genuinely good
Found states it partners exclusively with 503A-licensed pharmacies operating under Section 503A of the Federal Food, Drug, and Cosmetic Act, subject to both federal requirements and state board oversight, compounding against your specific prescription in facilities complying with USP sterile-preparation standards. Every batch is third-party tested for potency, purity and sterility.
It also publishes a comparison table stating plainly that its compounded lines hold one flat price at every dose with no separate membership, while branded Wegovy through Found runs $149–$349 depending on dose and requires a membership from $49/month. Publishing the weakness of your own branded option is not normal behaviour here.
What it actually costs per year
Advertised prices in this category are usually medication only. Add the membership back in and the ranking changes. Pick a provider, or enter the quote you were given.
One-month semaglutide rate. Starting at $79/month equivalent requires a 12-month plan ($948 total); confirm payment and renewal terms.
- First month
- $139
- Every month after
- $139
- Total over 12 months
- $1,668
No membership on this plan, so every dollar goes to medication and care.
Figures are the providers' own published prices as of our last review of each. Promotional rates, multi-month prepayment and dose changes can all move these numbers — confirm at checkout.
What compounded semaglutide actually is
Semaglutide is the active ingredient in Ozempic and Wegovy, both FDA-approved products from Novo Nordisk. A compounded version is prepared by a pharmacy rather than manufactured by Novo Nordisk, and it is not an FDA-approved product. FDA has not evaluated it for safety, effectiveness or quality.
That distinction is the single most important thing to understand before buying. The efficacy data you have read about — the 15% average body-weight reduction, the cardiovascular outcomes — comes from trials of the branded product. Those results are routinely used to sell compounded versions that were never in the trials.
Dosing typically starts at 0.25 mg weekly and escalates over several months toward a maintenance dose, which is why dose-dependent pricing matters so much: a plan that looks cheap at the starting dose can cost several times more by the time you reach a therapeutic one.
The common side effects are gastrointestinal — nausea, vomiting, diarrhoea, constipation — and are usually worst in the days after a dose increase. They are the main reason people stop. Slower titration and adequate fibre and fluid intake are the standard mitigations.
Before you buy from anyone
- Get the total monthly cost in writing — medication plus any membership, not the headline figure.
- Ask whether the price changes as your dose increases. This is where most of the money is lost.
- Ask which pharmacy compounds it, and whether it is a 503A or 503B facility.
- Confirm what happens if you stop after one month, and whether there is an auto-rebill.
- Ask whether a refund is available if a provider declines to prescribe.
- Tell the prescriber every medication and supplement you take, including anything bought online.